跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EYLEA 114,3 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EYLEA 114,3 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
EYLEA 114,3 MG/ML SOLUCION INYECTABLE
Bayer Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 9, 2024
Approval ID
b8aa2ab145555879
Company
Bayer Ag
Type
Standard
Approval Details
Approval Id
b8aa2ab145555879
Drug Cima Aemps Name
EYLEA 114,3 MG/ML SOLUCION INYECTABLE
Register Number
112797003
Holder Company Name
Bayer Ag
Marketing Company Name
Bayer Hispania S.L.
Holder Company Detail Path
/organization/bayer-ag
Authorization Date
2024-01-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
114,3 mg/ml
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Bayer Ag
Company Detail Path
/organization/bayer-ag
Company Information
Pharmaceutical Company Name
BAYER AG
Name En
Bayer AG
Country Name
Germany
City Name
Leverkusen
Address
Leverkusen, North Rhine-Westphalia, Germany
Website
https://www.bayer.com
Active Ingredients
AFLIBERCEPT
114,3 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 9, 2024
Approval ID
b8aa2ab145555879
Type
Standard
Back to CIMA-AEMPS Approvals